360 related articles for article (PubMed ID: 18486097)
1. Expression of vasohibin, an antiangiogenic factor, in human choroidal neovascular membranes.
Wakusawa R; Abe T; Sato H; Yoshida M; Kunikata H; Sato Y; Nishida K
Am J Ophthalmol; 2008 Aug; 146(2):235-243. PubMed ID: 18486097
[TBL] [Abstract][Full Text] [Related]
2. Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization.
Tong JP; Chan WM; Liu DT; Lai TY; Choy KW; Pang CP; Lam DS
Am J Ophthalmol; 2006 Mar; 141(3):456-62. PubMed ID: 16490490
[TBL] [Abstract][Full Text] [Related]
3. Expression of VEGF and angiopoietins in subfoveal membranes from patients with age-related macular degeneration.
Hera R; Keramidas M; Peoc'h M; Mouillon M; Romanet JP; Feige JJ
Am J Ophthalmol; 2005 Apr; 139(4):589-96. PubMed ID: 15808152
[TBL] [Abstract][Full Text] [Related]
4. Neuropilin-1 expression by endothelial cells and retinal pigment epithelial cells in choroidal neovascular membranes.
Lim JI; Spee C; Hangai M; Rocha J; Ying HS; Ryan SJ; Hinton DR
Am J Ophthalmol; 2005 Dec; 140(6):1044-1050. PubMed ID: 16376649
[TBL] [Abstract][Full Text] [Related]
5. Scavenger receptors for oxidized lipoprotein in age-related macular degeneration.
Kamei M; Yoneda K; Kume N; Suzuki M; Itabe H; Matsuda K; Shimaoka T; Minami M; Yonehara S; Kita T; Kinoshita S
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1801-7. PubMed ID: 17389514
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA.
Gu L; Chen H; Tuo J; Gao X; Chen L
Exp Eye Res; 2010 Sep; 91(3):433-9. PubMed ID: 20599960
[TBL] [Abstract][Full Text] [Related]
7. Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration.
Kikuchi M; Nakamura M; Ishikawa K; Suzuki T; Nishihara H; Yamakoshi T; Nishio K; Taki K; Niwa T; Hamajima N; Terasaki H
Ophthalmology; 2007 Sep; 114(9):1722-7. PubMed ID: 17400294
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of vascular endothelial growth factor implies the limbal origin of pterygia.
Gebhardt M; Mentlein R; Schaudig U; Pufe T; Recker K; Nölle B; Al-Samir K; Geerling G; Paulsen FP
Ophthalmology; 2005 Jun; 112(6):1023-30. PubMed ID: 15885787
[TBL] [Abstract][Full Text] [Related]
9. Suppression of choroidal neovascularization by vasohibin-1, a vascular endothelium-derived angiogenic inhibitor.
Wakusawa R; Abe T; Sato H; Sonoda H; Sato M; Mitsuda Y; Takakura T; Fukushima T; Onami H; Nagai N; Ishikawa Y; Nishida K; Sato Y
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3272-80. PubMed ID: 21345982
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor.
Economou MA; Wu J; Vasilcanu D; Rosengren L; All-Ericsson C; van der Ploeg I; Menu E; Girnita L; Axelson M; Larsson O; Seregard S; Kvanta A
Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2620-6. PubMed ID: 18515591
[TBL] [Abstract][Full Text] [Related]
11. Annexin A2 promotes choroidal neovascularization by increasing vascular endothelial growth factor expression in a rat model of argon laser coagulation-induced choroidal neovascularization.
Zhao SH; Pan DY; Zhang Y; Wu JH; Liu X; Xu Y
Chin Med J (Engl); 2010 Mar; 123(6):713-21. PubMed ID: 20368092
[TBL] [Abstract][Full Text] [Related]
12. Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice.
Koto T; Nagai N; Mochimaru H; Kurihara T; Izumi-Nagai K; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Oike Y; Ishida S
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4328-34. PubMed ID: 17724224
[TBL] [Abstract][Full Text] [Related]
13. VEGF expression and receptor activation in the choroid during development and in the adult.
Saint-Geniez M; Maldonado AE; D'Amore PA
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3135-42. PubMed ID: 16799060
[TBL] [Abstract][Full Text] [Related]
14. Suppression of choroidal neovascularization by vaccination with epitope peptide derived from human VEGF receptor 2 in an animal model.
Takahashi H; Ishizaki H; Tahara H; Tamaki Y; Yanagi Y
Invest Ophthalmol Vis Sci; 2008 May; 49(5):2143-7. PubMed ID: 18436847
[TBL] [Abstract][Full Text] [Related]
15. [Expression of vascular endothelial growth factor and its receptor in experimental choroidal neovascularization in rat].
Zhao SH; He SZ; Shi XH
Zhonghua Yan Ke Za Zhi; 2004 Aug; 40(8):522-7. PubMed ID: 15454039
[TBL] [Abstract][Full Text] [Related]
16. Differences in the temporal expression of regulatory growth factors during choroidal neovascular development.
Hu W; Criswell MH; Fong SL; Temm CJ; Rajashekhar G; Cornell TL; Clauss MA
Exp Eye Res; 2009 Jan; 88(1):79-91. PubMed ID: 19013152
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of choroidal neovascularization by adenovirus-mediated delivery of short hairpin RNAs targeting VEGF as a potential therapy for AMD.
Cashman SM; Bowman L; Christofferson J; Kumar-Singh R
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3496-504. PubMed ID: 16877421
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of vasohibin-2 as a homologue of VEGF-inducible endothelium-derived angiogenesis inhibitor vasohibin.
Shibuya T; Watanabe K; Yamashita H; Shimizu K; Miyashita H; Abe M; Moriya T; Ohta H; Sonoda H; Shimosegawa T; Tabayashi K; Sato Y
Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1051-7. PubMed ID: 16528006
[TBL] [Abstract][Full Text] [Related]
19. Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization.
Grossniklaus HE; Ling JX; Wallace TM; Dithmar S; Lawson DH; Cohen C; Elner VM; Elner SG; Sternberg P
Mol Vis; 2002 Apr; 8():119-26. PubMed ID: 11979237
[TBL] [Abstract][Full Text] [Related]
20. Expressions of angiopoietins and Tie2 in human choroidal neovascular membranes.
Otani A; Takagi H; Oh H; Koyama S; Matsumura M; Honda Y
Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):1912-20. PubMed ID: 10440243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
